Flowers Foods (NYSE: FLO) is voluntarily recalling the following brands of Bar-B-Q bread because they may contain undeclared milk. People who have allergies to dairy products run the risk of serious or life-threatening allergic reaction if they consume these products. No illnesses have been reported to date.
Read The Complete Story!
Category Archives: Food & Drug Recalls
FDA outlines expectations for human drug compounders, including registered outsourcing facilities
Today, the U.S. Food and Drug Administration issued several policy documents regarding compounded drug products for human use, as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act (DQSA), enacted in November 2013. The policy documents consist of a draft interim guidance, a proposed rule, a final guidance, and two revised requests for nominations for the bulk drug substances lists.
Richard’s Rubs & Seasonings Recalls Sauces Because of Possible Health Risk
Richard’s Rubs & Seasonings LLC is recalling Richard’s Too Good BBQ Sauce, Richard’s Too Good Hot Sauce and Richard’s Too Good Teriyaki Sauce because they may have been improperly processed and because they may have the potential to be contaminated with Clostridium botulinum, which can cause botulism, a serious and potentially fatal foodborne illness.
Nestlé USA Issues Recall Of Limited Amounts Of Häagen-Dazs® Chocolate Chocolate Chip Ice Cream In East Coast Region Due To Mismatched Packaging
Nestlé USA is initiating a recall of limited amounts of ice cream due to mismatched packaging. The affected products are 14-ounce cartons labeled as Häagen-Dazs Chocolate Chocolate Chip Ice Cream with a UPC of 74570-08400, and lid labeled as Häagen-Dazs Chocolate Peanut Butter.
FDA approves Afrezza to treat diabetes
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
Health Matters America Inc. Of Cheektowaga, New York, Recalls Additional Sprouted Chia Seed And Sprouted Chia & Flax Seed Powder Due To Possible Health Risk
HEALTH MATTERS AMERICA INC. of Cheektowaga, New York is expanding the voluntary recall of Organic Traditions Sprouted Chia Seed Powder and Sprouted Chia& Flax Seed Powder due to possible Salmonella contamination, an organism that can cause serious and sometimes fatal infections in young children, elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain.
FDA allows marketing of first wearable, motorized device that helps people with certain spinal cord injuries to walk
The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for people with lower body paralysis (paraplegia) due to a spinal cord injury. ReWalk is a motorized device worn over the legs and part of the upper body that helps an individual sit, stand, and walk with assistance from a trained companion, such as a spouse or home health aide.
Kentucky oncology practice and its manager plead guilty to purchasing and selling unapproved chemotherapy drugs
Hematology and Oncology Center (HOC) PLLC of Somerset, Kentucky has pleaded guilty to federal charges that the firm purchased and sold unapproved and improperly labeled chemotherapy drugs. HOC’s former office manager, Natarajan Murugesan, also pleaded guilty to assisting with these activities, which are violations of the Federal Food, Drug, and Cosmetic Act. The charges were brought by the U.S. Attorney’s Office for the Eastern District of Kentucky.
Doctor’s Best Issues Voluntary Nationwide Recall of Red Yeast Rice due to Undeclared Lovastatin
Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level.
FDA issues guidance to support the responsible development of nanotechnology products
Today, three final guidances and one draft guidance were issued by the U.S. Food and Drug Administration providing greater regulatory clarity for industry on the use of nanotechnology in FDA-regulated products.